|
Price: $30.8600
$0.01 
0.032%
|
| Day's High:
| $30.89
| Week Perf:
| 0.06 %
|
| Day's Low: |
$ 30.86 |
30 Day Perf: |
0.62 % |
| Volume (M): |
439 |
52 Wk High: |
$ 31.06 |
| Volume (M$): |
$ 13,541 |
52 Wk Avg: |
$21.14 |
| Open: |
$30.89 |
52 Wk Low: |
$15.09 |
|
|
| Market Capitalization (Millions $) |
1,078 |
| Shares
Outstanding (Millions) |
35 |
| Employees |
3,500 |
| Revenues (TTM) (Millions $) |
1,133 |
| Net Income (TTM) (Millions $) |
14 |
| Cash Flow (TTM) (Millions $) |
6 |
| Capital Exp. (TTM) (Millions $) |
8 |
Petiq Inc
PetIQ Inc is a leading pet care company based in Eagle, Idaho, that specializes in providing a wide range of affordable pet health and wellness products and services. The company operates through three primary segments: veterinary services, retail and e-commerce, and product. PetIQ Inc has quickly established itself as a trusted provider of high-quality, affordable veterinary services, medications, and pet products for cats and dogs.
The veterinary services segment of PetIQ Inc comprises a rapidly growing network of veterinary clinics and hospitals, which offer a range of services such as routine checkups, preventive care, dental services, and vaccinations. The clinics are staffed by licensed veterinarians, trained veterinary technicians, and experienced support staff who are committed to exceptional care for pets. PetIQ's veterinary services aim to provide convenient, high-quality care at a reasonable cost and offer pet owners an alternative to traditional veterinary practices.
The retail and e-commerce segment offers pet owners a convenient way to purchase a wide range of pet products and medications online and in-store. PetIQ operates over 70 retail stores across the United States, which are located in high-traffic retail centers like Walmart and Target. Additionally, PetIQ has an online store that offers a wide range of pet products, including food, toys, grooming and hygiene products, flea and tick medications, and more. The company's e-commerce operations, like the retail stores, aim to offer affordable pet products to pet owners across the country.
The product segment of PetIQ consists of a wide range of patented pet health and wellness products, including well-known brands such as Advecta, PetArmor and VetIQ. The product segment features a range of affordable and effective pet health products, from flea and tick treatments to dental care products. PetIQ's product offerings alongside its veterinary services, aim to provide pet owners a one-stop-shop for their pets' health and wellness needs.
In conclusion, PetIQ Inc is a leading pet care company that offers high-quality veterinary services, affordable retail products, and innovative wellness products, thus positioning the company as a go-to provider for all pet care needs. PetIQ's focus on expanding its e-commerce capabilities, clinical offerings and established brands, makes it an important player in the rapidly growing pet care industry.
Company Address: 230 E. Riverside Drive Eagle 83616 ID
Company Phone Number: 939-8900 Stock Exchange / Ticker: NASDAQ PETQ
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
| Merger and Acquisition
Published Wed, Aug 7 2024 12:00 PM UTC
In a significant development in the pet healthcare industry, PetIQ, Inc. (NASDAQ: PETQ) has announced a definitive agreement to be acquired by Bansk Group. This all-cash transaction, valued at approximately $1.5 billion, will see PetIQ stockholders receiving $31.00 per share. This announcement marks a pivotal moment for the company, which has been a prominent player in ...
|
| Petiq Inc
The stock market has been buzzing with excitement as PetIQ Inc, a leading pet medication and health company, recently announced its impressive financial results for the first quarter of 2024 earnings season. Investors are thrilled to see that the company's profit per share has jumped by a remarkable 50% to $0.48 per share, compared to $0.32 per share the previous year. Furthermore, PetIQ Inc has seen a significant turnaround in its earnings per share, which have turned positive from a negative $-0.60 per share in the previous reporting period.
Not only has PetIQ Inc excelled in terms of profitability, but its revenue growth is equally impressive. The company's revenue has grown by 5.877% to $307.54 million from $290.47 million in the corresponding reporting period a year ago. Moreover, the sequential revenue has surged by an astounding 39.299% from $220.78 million. This remarkable growth in revenue has positioned PetIQ Inc as a clear frontrunner in its industry. While the Pharmacy Services & Retail Drugstore industry only saw a 5.59% rise in top-line revenue during the same period, PetIQ Inc has outperformed its industry contemporaries.
|
| Product Service News
Published Thu, Mar 14 2024 1:00 PM UTC
PetIQ, Inc.'s Innovative Expansion of Minties Dental Treats Brand Brings Fresh Breath and Dental Health to Large-Sized DogsIn a bid to further enhance pet oral health and freshen their breath, PetIQ, Inc. announced the expansion of their popular Minties Dental Treats brand. The company has introduced a new dental chew specifically designed for large-sized dogs, catering to ...
|
| Product Service News
Published Thu, Mar 7 2024 3:00 PM UTC
Subtitle: Vet-Recommended NextStar Kills, Protects, and Prevents Without a Prescription; PetIQ's Telehealth Support Line Connects Pet Parents with Real-Time, Live Veterinary ProfessionalsFlea and tick season is here, and PetIQ, Inc., a leading pet health and wellness company, is stepping up to educate pet parents and offer comprehensive veterinary support through their NextS...
|
| Petiq Inc
PETQ Reports Increased Loss Per Share for Recent Fiscal Period
EAGLE, Idaho, Feb. 07, 2024 - PetIQ, Inc. (PetIQ or the Company) (Nasdaq: PETQ), a leading pet medication and wellness company, announced its financial results for the fourth quarter and full year ended December 31, 2023. Despite some unfavorable numbers, the company remains optimistic about its future performance.
For the most recent fiscal period, PETQ reported a loss per share of $-0.60, compared to $-0.24 in the previous year. The Income per Share also fell from $0.02 to -$0.60 sequentially. However, there was a notable increase in revenue, which grew by 19.937% to $220.78 million from $184.08 million in the same quarter of the previous year.
|
| Per Share |
Current |
| Earnings (TTM) |
0.39 $ |
| Revenues (TTM) |
32.43 $
|
| Cash Flow (TTM) |
0.16 $ |
| Cash |
2.41 $
|
| Book Value |
-
|
| Dividend (TTM) |
0 $ |
|
|
| Per Share |
|
| Earnings (TTM) |
0.39 $
|
| Revenues (TTM) |
32.43 $ |
| Cash Flow (TTM) |
0.16 $ |
| Cash |
2.41 $
|
| Book Value |
- |
| Dividend (TTM) |
0 $ |
|
|
| |
| Products |
|
 88.53 % |
of total Revenue |
| Services |
|
11.47 % |
of total Revenue |
| United States |
|
99.53 % |
of total Revenue |
| United States Products |
|
88.06 % |
of total Revenue |
| United States Services |
|
11.47 % |
of total Revenue |
| Foreign |
|
0.47 % |
of total Revenue |
| Foreign Products |
|
0.47 % |
of total Revenue |
| United States Products |
|
88.06 % |
of total Revenue |
| United States Services |
|
11.47 % |
of total Revenue |
| Foreign Products |
|
0.47 % |
of total Revenue |
|
|
